Stimulating Neuroplasticity for Therapeutic Benefits Inspired by Psychedelic Research
26 min
Stimulating Neuroplasticity for Therapeutic Benefits Inspired by Psychedelic Research
High On Healthy
0:00--:--
Richard Zwicky spoke with Dr. Joseph Tucker, CEO of Enveric Biosciences about their development of non-hallucinogenic neuroplastogens, inspired by psychedelic research, to stimulate neuroplasticity for therapeutic benefits. Dr. Tucker explained the distinction from psychedelics, the potential for regular use due to a shorter duration of effect, and the challenges in translating psychedelic treatments. They also discussed the application to PTSD, integration into the mental health landscape with potential for greater accessibility and cost-effectiveness, the timeline for clinical trials aiming for market availability in the early 2030s, and the future of mental health treatment where both approaches could coexist.
Enjoy this episode?
Subscribe to High On Healthy for new episodes.
More from High On Healthy
Bridging Worlds: Where Western Medicine Meets Shamanic Healing
High On Healthy
In this episode of High on Healthy , host Richard Zwicky sits down with Dr. Sandra Bailey, a registered nurse and holistic practitioner who navigates the intersection of conventional healthcare and ancient shamanic traditions.